Aquestive Therapeutics, Inc. (AQST) — Business segments and KPIs
Revenue by business segment and geography for Aquestive Therapeutics, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Manufacture and Supply Revenue | 40.23M | 89.3% |
| License and Royalty Revenue | 3.52M | 7.8% |
| Co-Development and Research Fees | 1.28M | 2.8% |
| Revenue by region | ||
| UNITED STATES | 29.60M | 66.5% |
| Non-US | 14.94M | 33.5% |